Azenta, Inc. (AZTA) Analyst/Investor Day Transcript

Azenta, Inc. (AZTA) Analyst/Investor Day Transcript

Seeking Alpha • Dec 11, 2025

Azenta Authorizes $250 Million Share Repurchase Program

BURLINGTON, Mass. , Dec. 10, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its Board of Directors has approved a share repurchase program under which the company may repurchase up to $250 million of its outstanding common stock.

PRNewsWire • Dec 10, 2025

New Strong Sell Stocks for December 9th

BRBR, AZTA and BRDCY have been added to the Zacks Rank #5 (Strong Sell) List on December 9, 2025.

Zacks Investment Research • Dec 9, 2025

Why a $5 Million Bet on Azenta Could Pay Off After a 70% Stock Slide

Dallas-based Meros Investment Management purchased 159,945 shares of Azenta valued at $4.6 million in the third quarter. The position represents 2% of Meros's 13F reportable assets under management.

The Motley Fool • Dec 8, 2025

Azenta, Inc. (AZTA) Q4 2025 Earnings Call Transcript

Azenta, Inc. ( AZTA ) Q4 2025 Earnings Call November 21, 2025 8:30 AM EST Company Participants Yvonne Perron - Vice President of Financial Planning & Analysis and Investor Relations John P. Marotta - President, CEO & Director Lawrence Lin - Executive VP & CFO Conference Call Participants David Saxon - Needham & Company, LLC, Research Division Steven Etoch - Stephens Inc., Research Division Andrew Cooper - Raymond James & Associates, Inc., Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Jacqueline Kisa - TD Cowen, Research Division Paul Knight - KeyBanc Capital Markets Inc., Research Division Presentation Operator Greetings, and welcome to the Azenta Q4 2025 Financial Results.

Seeking Alpha • Nov 21, 2025

Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025

Q4'25 reported revenue growth of 6% year over year and 4% on an organic basis FY'25 reported revenue growth of 4% and 3% on an organic basis FY'25 Adjusted EBITDA margin expansion of 310 basis points versus last year FY'26 organic revenue growth expected to be 3% to 5% year over year, with Adjusted EBITDA margin expansion of approximately 300 basis points BURLINGTON, Mass. , Nov. 21, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2025.

PRNewsWire • Nov 21, 2025

Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast

BURLINGTON, Mass. , Nov. 12, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2025 earnings which ended on September 30, 2025, on Friday, November 21, 2025, before the market opens.

PRNewsWire • Nov 12, 2025

Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer

BURLINGTON, Mass. , Nov. 4, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with the PRECEDE Foundation, an international, multi-institutional collaborative focused on early detection and prevention of pancreatic cancer.

PRNewsWire • Nov 4, 2025

Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana

BURLINGTON, Mass. , Oct. 15, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it will host an Investor Day on Wednesday, December 10, 2025, at the Company's biorepository facility in Indianapolis, Indiana.

PRNewsWire • Oct 15, 2025

Azenta (AZTA) Q3 EPS Jumps 36%

Azenta (AZTA) Q3 EPS Jumps 36%

The Motley Fool • Aug 5, 2025